Latest stories on APVO
Aptevo highlights promising AML transplant outcomes with mipletamig
TipRanks64 · neutralproduct/pr
Aptevo says 10 patients with AML advanced to allogeneic stem cell transplant
The Fly63 · neutralproduct/pr
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo to Present CD40 Multispecific Cancer Platform
TipRanks58 · neutralproduct/pr
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting
StockTitan56 · neutralproduct/pr
Aptevo Therapeutics advances trispecific candidate toward clinical development
The Fly63 · neutralproduct/pr
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
StockTitan63 · neutralproduct/pr
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo AML data ‘highly encouraging,’ says Roth Capital
The Fly67 · bullishproduct/pr
Why is Aptevo Therapeutics stock slumping today?
Investing.com Markets34 · bearishgeneral
Aptevo Therapeutics’ mipletamig triplet shows 93% benefit in leukemia
The Fly73 · bullishproduct/pr
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
StockTitan73 · bullishproduct/pr
Aptevo Therapeutics files to sell 6.44M shares of common stock for holders
The Fly28 · bearishgeneral
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo Therapeutics announces exercise of warrants, PIPE for $4.5M in proceeds
The Fly24 · bearishgeneral
Aptevo Therapeutics reports $9.8M in cash, cash equivalents as of June 30
The Fly50 · neutralgeneral
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo Therapeutics reports Q2 results
Seeking Alpha50 · neutralearnings
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
StockTitan56 · neutralearnings
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral